Palisade Bio, Inc.
PALI
$1.87
-$0.05-2.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.86M | 5.35M | 5.28M | 5.70M | 5.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.06M | 11.46M | 12.13M | 13.50M | 14.86M |
| Operating Income | -18.06M | -11.46M | -12.13M | -13.50M | -14.86M |
| Income Before Tax | -16.78M | -11.23M | -11.85M | -13.14M | -14.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.78 | -11.23 | -11.85 | -13.14 | -14.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.78M | -11.23M | -11.85M | -13.14M | -14.44M |
| EBIT | -18.06M | -11.46M | -12.13M | -13.50M | -14.86M |
| EBITDA | -18.05M | -11.45M | -12.13M | -13.49M | -14.86M |
| EPS Basic | -1.47 | -2.98 | -4.92 | -7.66 | -11.78 |
| Normalized Basic EPS | -0.92 | -1.86 | -3.07 | -4.79 | -7.37 |
| EPS Diluted | -1.47 | -2.98 | -4.92 | -7.66 | -11.78 |
| Normalized Diluted EPS | -0.92 | -1.86 | -3.07 | -4.79 | -7.37 |
| Average Basic Shares Outstanding | 222.64M | 19.23M | 13.25M | 9.69M | 5.66M |
| Average Diluted Shares Outstanding | 222.64M | 19.23M | 13.25M | 9.69M | 5.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |